- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2005
- Public Summary Document (PSD) November 2005 PBAC Meeting - PDF
Cetuximab – November 2005
Cetuximab, solution for IV infusion, 100 mg in 50 mL, Erbitux®, November 2005
Last updated
27 February 2006